MX2022013674A - Estimulacion del crecimiento de bifidobacterias intestinales. - Google Patents
Estimulacion del crecimiento de bifidobacterias intestinales.Info
- Publication number
- MX2022013674A MX2022013674A MX2022013674A MX2022013674A MX2022013674A MX 2022013674 A MX2022013674 A MX 2022013674A MX 2022013674 A MX2022013674 A MX 2022013674A MX 2022013674 A MX2022013674 A MX 2022013674A MX 2022013674 A MX2022013674 A MX 2022013674A
- Authority
- MX
- Mexico
- Prior art keywords
- growth
- gut
- compositions
- stimulation
- bifidobacteria
- Prior art date
Links
- 241000186000 Bifidobacterium Species 0.000 title abstract 2
- 230000000638 stimulation Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000027244 Dysbiosis Diseases 0.000 abstract 1
- 241000186840 Lactobacillus fermentum Species 0.000 abstract 1
- 230000007140 dysbiosis Effects 0.000 abstract 1
- 229940012969 lactobacillus fermentum Drugs 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente divulgación proporciona composiciones para estimular el crecimiento de las bifidobacterias intestinales, manteniendo/mejorando así la salud intestinal. De particular interés son las composiciones que comprenden células de Lactobacillus fermentum, incluyendo el producto LACTEOL(r). Ejemplos de afecciones específicas que pueden tratarse con las composiciones incluyen diarrea asociada a antibióticos, disbiosis, síndrome del intestino irritable (SII) y enfermedad inflamatoria intestinal (EII).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018908P | 2020-05-01 | 2020-05-01 | |
| PCT/EP2021/061392 WO2021219846A1 (en) | 2020-05-01 | 2021-04-30 | Stimulation of the growth of gut bifidobacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013674A true MX2022013674A (es) | 2022-11-30 |
Family
ID=75801585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013674A MX2022013674A (es) | 2020-05-01 | 2021-04-30 | Estimulacion del crecimiento de bifidobacterias intestinales. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240082321A1 (es) |
| EP (1) | EP4142757A1 (es) |
| JP (1) | JP2023523221A (es) |
| KR (1) | KR20230005919A (es) |
| CN (1) | CN115484968A (es) |
| CA (1) | CA3174269A1 (es) |
| MX (1) | MX2022013674A (es) |
| WO (1) | WO2021219846A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114917256A (zh) * | 2022-04-15 | 2022-08-19 | 广西大学 | 用于鸡胚卵内注射的微生态制剂及其制备方法 |
| CN117143767A (zh) * | 2023-08-23 | 2023-12-01 | 浙江民生健康科技有限公司 | 可调节肠道菌群的母乳源发酵粘液乳杆菌msjk0025及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210003746A (ko) * | 2018-03-22 | 2021-01-12 | 아다레 파마수티칼스 에스아에스 | 미생물학적 조성물의 신규 용도 |
-
2021
- 2021-04-30 EP EP21723695.9A patent/EP4142757A1/en active Pending
- 2021-04-30 MX MX2022013674A patent/MX2022013674A/es unknown
- 2021-04-30 KR KR1020227041640A patent/KR20230005919A/ko unknown
- 2021-04-30 WO PCT/EP2021/061392 patent/WO2021219846A1/en unknown
- 2021-04-30 JP JP2022563988A patent/JP2023523221A/ja active Pending
- 2021-04-30 US US17/922,636 patent/US20240082321A1/en active Pending
- 2021-04-30 CN CN202180031341.3A patent/CN115484968A/zh active Pending
- 2021-04-30 CA CA3174269A patent/CA3174269A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023523221A (ja) | 2023-06-02 |
| KR20230005919A (ko) | 2023-01-10 |
| CA3174269A1 (en) | 2021-11-04 |
| US20240082321A1 (en) | 2024-03-14 |
| WO2021219846A1 (en) | 2021-11-04 |
| CN115484968A (zh) | 2022-12-16 |
| EP4142757A1 (en) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roselli et al. | Immunomodulating effects of probiotics for microbiota modulation, gut health and disease resistance in pigs | |
| Scaldaferri et al. | Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility | |
| Mileti et al. | Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy | |
| MX2022013674A (es) | Estimulacion del crecimiento de bifidobacterias intestinales. | |
| WO2019066599A3 (ko) | 신규 유산균 및 이의 용도 | |
| Eom et al. | Protective effects of a novel probiotic strain of Lactobacillus plantarum JSA22 from traditional fermented soybean food against infection by Salmonella enterica serovar Typhimurium | |
| JP2015213501A5 (es) | ||
| MX2008006546A (es) | Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria. | |
| Kong et al. | Evaluation of cholesterol lowering property and antibacterial activity of two potential lactic acid bacteria isolated from the intestine of snakehead fish (Channa argus) | |
| EE05799B1 (et) | Hüpokolestereemilist probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ennetamiseks | |
| MX2022000369A (es) | Cepa bacteriana de bifidobacterium bifidum, las composiciones de la misma y usos relacionados. | |
| MX2021009398A (es) | Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso. | |
| BR112021026278A2 (pt) | Composições farmacêuticas, composições alimentícias, usos de uma composição, método de tratamento da doença inflamatória intestinal e método para inibir a inflamação | |
| KR20220091695A (ko) | 프로바이오틱 기능이 있는 신규의 락토바실러스 류테리 efel6901 발효 종균 | |
| Sandagdorj et al. | Characterization of microbiota that influence immunomodulatory effects of fermented Brassica rapa L | |
| Lai et al. | Isolation of exopolysaccharide producing Lactobacillus strains from sorghum distillery residues pickled cabbage and their antioxidant properties | |
| EA202191106A1 (ru) | Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus | |
| WO2020154523A3 (en) | Methods and compositions for treating intestinal disorder | |
| Husáková et al. | Expression of cytokines in chicken peripheral mononuclear blood cells (PMBCs) exposed to probiotic strains and Salmonella Enteritidis | |
| Yu et al. | Effects of the probiotics supplementation in diet on intestinal microflora ecosystem in broilers | |
| Khedr et al. | FolE gene expression for folic acid productivity from optimized and characterized probiotic Lactobacillus delbrueckii | |
| EP1930018A1 (en) | Strains of probiotic lactobacilli that persist in the intestine and modulate its mucosal receptors | |
| Shin et al. | Probiotic Properties and Immunomodulator Evaluation of the Potential Feed Additive Pediococcus acidilactici SRCM102607 | |
| Zhang et al. | Postbiotics from Pichia kudriavzevii promote intestinal health performance through regulation of Limosilactobacillus reuteri in weaned piglets | |
| JP7479620B1 (ja) | リポ多糖、リポ多糖製造方法及びリポ多糖配合物 |